Washington Trust Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
JT
SC
Washington Trust Advisors's GMED Position: Q2 2026 in Review
Washington Trust Advisors increased its Globus Medical (GMED) stake by 117% in Q2 2026, buying an estimated $2.06M and bringing the position to 45,006 shares worth $3.56M. The position accounts for 0.26% of the portfolio, ranked #65.
Washington Trust Advisors first reported a position in GMED in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.3M in Q1 2022. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Washington Trust Advisors held 45,006 shares of Globus Medical worth $3.56M as of Q2 2026.
- Washington Trust Advisors bought 24,250 Globus Medical shares in Q2 2026, an estimated $2.06M.
- Globus Medical made up 0.26% of Washington Trust Advisors's portfolio in Q2 2026, its #65 holding.
- Washington Trust Advisors first reported a position in Globus Medical in Q4 2021 and has held it in 19 quarters since.
- Washington Trust Advisors's Globus Medical position peaked at $13.3M in Q1 2022.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.